Identification of an Immunologic Signature of Lung Adenocarcinomas Based on Genome-Wide Immune Expression Profiles

Background: Lung cancer is one of the most common types of cancer, and it has a poor prognosis. It is urgent to identify prognostic biomarkers to guide therapy. Methods: The immune gene expression profiles for patients with lung adenocarcinomas (LUADs) were obtained from The Cancer Genome Atlas (TCG...

Descripción completa

Detalles Bibliográficos
Autores principales: Ling, Bo, Ye, Guangbin, Zhao, Qiuhua, Jiang, Yan, Liang, Lingling, Tang, Qianli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832236/
https://www.ncbi.nlm.nih.gov/pubmed/33505988
http://dx.doi.org/10.3389/fmolb.2020.603701

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832236/
https://www.ncbi.nlm.nih.gov/pubmed/33505988
http://dx.doi.org/10.3389/fmolb.2020.603701

Ejemplares similares